Pistis, Marco
Pistis, Marco
Istituto di Neuroscienze - IN -
Profound Modification of Fatty Acid Profile and Endocannabinoid-Related Mediators in PPAR? Agonist Fenofibrate-Treated Mice
2022 Elisabetta Murru ; Anna Lisa Muntoni ; Claudia Manca ; Sonia Aroni ; Marco Pistis ; ; Sebastiano Banni ; Gianfranca Carta
N-Acylethanolamine Acid Amidase Inhibition Potentiates Morphine Analgesia and Delays the Development of Tolerance
2021 Congiu M.; Micheli L.; Santoni M.; Sagheddu C.; Muntoni A.L.; Makriyannis A.; Malamas M.S.; Ghelardini C.; Di Cesare Mannelli L.; Pistis M.
Repeated exposure to JWH-018 induces adaptive changes in the mesolimbic and mesocortical dopaminergic pathways, glial cells alterations, and behavioural correlates
2021 Pintori N.; Castelli M.P.; Miliano C.; Simola N.; Fadda P.; Fattore L.; Scherma M.; Ennas M.G.; Mostallino R.; Flore G.; De Felice M.; Sagheddu C.; Pistis M.; Di Chiara G.; De Luca M.A.
Repurposing peroxisome proliferator-activated receptor agonists in neurological and psychiatric disorders
2021 Sagheddu, C; Melis, M; Muntoni, Al; Pistis, M
delta 9 Tetrahydrocannabinol During Adolescence Attenuates Disruption of Dopamine Function Induced in Rats by Maternal Immune Activation
2019 Lecca, Salvatore; Luchicchi, Antonio; Scherma, Maria; Fadda, Paola; Muntoni, ANNA LISA; Pistis, Marco
Exposure to tobacco smoke during the early postnatal period modifies receptors and enzymes of the endocannabinoid system in the brainstem and striatum in mice
2019 Torres, Lh; Balestrin, Nt; Spelta, Lew; Duro, Sdo; Pistis, M; Marcourakis, T
Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward
2019 Sagheddu, C; Scherma, M; Congiu, M; Fadda, P; Carta, G; Banni, S; Wood, Jt; Makriyannis, A; Malamas, Ms; Pistis, M
The novel atypical dopamine uptake inhibitor (S)-CE-123 partially reverses the effort-related effects of the dopamine depleting agent tetrabenazine and increases progressive ratio responding
2019 Rotolo R.A.; Dragacevic V.; Kalaba P.; Urban E.; Zehl M.; Roller A.; Wackerlig J.; Langer T.; Pistis M.; De Luca M.A.; Caria F.; Schwartz R.; Presby R.E.; Yang J.H.; Samels S.; Correa M.; Lubec G.; Salamone J.D.
The PPAR alpha agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia
2019 De Felice, Marta; Melis, Miriam; Aroni, Sonia; Muntoni, Anna Lisa; Fanni, Silvia; Frau, Roberto; Devoto, Paola; Pistis, Marco
Oltre gli endocannabinoidi: ruolo dei neuromodulatori lipidici nelle tossicodipendenze
2018 Congiu, M; Sagheddu, C; Melis, M; Muntoni, Al; Pistis, M
Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy
2017 Puligheddu, M; Melis, M; Pillolla, G; Milioli, G; Parrino, L; Terzano, Gm; Aroni, S; Sagheddu, C; Marrosu, F; Pistis, M; Muntoni, Al
Roles of N-acylethanolamines in brain functions and neuropsychiatric diseases
2017 Pistis M.; Muntoni A.L.
Adolescent D9-Tetrahydrocannabinol Exposure Alters WIN55,212-2 Self-Administration in Adult Rats
2016 Scherma, M.; Dessì, C.; Muntoni, A.L.; Lecca, S.; Satta, V.; Luchicchi, L.; Pistis, M.; Panlilio, L.V.; Fattore, L.; Goldberg, S.R.; Fratta, W.; Fadda, P.
Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives
2016 Scherma M.; Muntoni A.L.; Melis M.; Fattore L.; Fadda P.; Fratta W.; Pistis M.
Maternal immune activation disrupts dopamine system in the offspring
2016 Luchicchi A.; Lecca S.; Melis M.; De Felice M.; Cadeddu F.; Frau R.; Muntoni A.L.; Fadda P.; Devoto P.; Pistis M.
PPAR modulation of mesolimbic dopamine transmission rescues depression-related behaviors
2016 Scheggi S.; Melis M.; De Felice M.; Aroni S.; Muntoni A.L.; Pelliccia T.; Gambarana C.; De Montis M.G.; Pistis M.
Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling
2015 Dudok, B; Barna, L; Ledri, M; Szabo, Si; Szabadits, E; Pinter, B; Woodhams, Sg; Henstridge, Cm; Balla, Gy; Nyilas, R; Varga, C; Lee, Sh; Matolcsi, M; Cervenak, J; Kacskovics, I; Watanabe, M; Sagheddu, C; Melis, M; Pistis, M; Soltesz, I; Katona, I
Endocannabinoid Signaling in Motivation, Reward, and Addiction: Influences on Mesocorticolimbic Dopamine Function
2015 Sagheddu, C; Muntoni, Al; Pistis, M; Melis, M
Enhanced serotonin and mesolimbic dopamine transmissions in a rat model of neuropathic pain
2015 Sagheddu, C; Aroni, S; De Felice, M; Lecca, S; Luchicchi, A; Melis, M; Muntoni, Al; Romano, R; Palazzo, E; Guida, F; Maione, S; Pistis, M
Enhanced endocannabinoid-mediated modulation of rostromedial tegmental nucleus drive onto dopamine neurons in sardinian alcohol-preferring rats
2014 Melis, M; Sagheddu, C; Felice, Md; Casti, A; Madeddu, C; Spiga, S; Muntoni, Al; Mackie, K; Marsicano, G; Colombo, G; Castelli, Mp; Pistis, M
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Profound Modification of Fatty Acid Profile and Endocannabinoid-Related Mediators in PPAR? Agonist Fenofibrate-Treated Mice | 1-gen-2022 | Elisabetta Murru ; Anna Lisa Muntoni ; Claudia Manca ; Sonia Aroni ; Marco Pistis ; ; Sebastiano Banni ; Gianfranca Carta | |
| N-Acylethanolamine Acid Amidase Inhibition Potentiates Morphine Analgesia and Delays the Development of Tolerance | 1-gen-2021 | Congiu M.; Micheli L.; Santoni M.; Sagheddu C.; Muntoni A.L.; Makriyannis A.; Malamas M.S.; Ghelardini C.; Di Cesare Mannelli L.; Pistis M. | |
| Repeated exposure to JWH-018 induces adaptive changes in the mesolimbic and mesocortical dopaminergic pathways, glial cells alterations, and behavioural correlates | 1-gen-2021 | Pintori N.; Castelli M.P.; Miliano C.; Simola N.; Fadda P.; Fattore L.; Scherma M.; Ennas M.G.; Mostallino R.; Flore G.; De Felice M.; Sagheddu C.; Pistis M.; Di Chiara G.; De Luca M.A. | |
| Repurposing peroxisome proliferator-activated receptor agonists in neurological and psychiatric disorders | 1-gen-2021 | Sagheddu, C; Melis, M; Muntoni, Al; Pistis, M | |
| delta 9 Tetrahydrocannabinol During Adolescence Attenuates Disruption of Dopamine Function Induced in Rats by Maternal Immune Activation | 1-gen-2019 | Lecca, Salvatore; Luchicchi, Antonio; Scherma, Maria; Fadda, Paola; Muntoni, ANNA LISA; Pistis, Marco | |
| Exposure to tobacco smoke during the early postnatal period modifies receptors and enzymes of the endocannabinoid system in the brainstem and striatum in mice | 1-gen-2019 | Torres, Lh; Balestrin, Nt; Spelta, Lew; Duro, Sdo; Pistis, M; Marcourakis, T | |
| Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward | 1-gen-2019 | Sagheddu, C; Scherma, M; Congiu, M; Fadda, P; Carta, G; Banni, S; Wood, Jt; Makriyannis, A; Malamas, Ms; Pistis, M | |
| The novel atypical dopamine uptake inhibitor (S)-CE-123 partially reverses the effort-related effects of the dopamine depleting agent tetrabenazine and increases progressive ratio responding | 1-gen-2019 | Rotolo R.A.; Dragacevic V.; Kalaba P.; Urban E.; Zehl M.; Roller A.; Wackerlig J.; Langer T.; Pistis M.; De Luca M.A.; Caria F.; Schwartz R.; Presby R.E.; Yang J.H.; Samels S.; Correa M.; Lubec G.; Salamone J.D. | |
| The PPAR alpha agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia | 1-gen-2019 | De Felice, Marta; Melis, Miriam; Aroni, Sonia; Muntoni, Anna Lisa; Fanni, Silvia; Frau, Roberto; Devoto, Paola; Pistis, Marco | |
| Oltre gli endocannabinoidi: ruolo dei neuromodulatori lipidici nelle tossicodipendenze | 1-gen-2018 | Congiu, M; Sagheddu, C; Melis, M; Muntoni, Al; Pistis, M | |
| Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy | 1-gen-2017 | Puligheddu, M; Melis, M; Pillolla, G; Milioli, G; Parrino, L; Terzano, Gm; Aroni, S; Sagheddu, C; Marrosu, F; Pistis, M; Muntoni, Al | |
| Roles of N-acylethanolamines in brain functions and neuropsychiatric diseases | 1-gen-2017 | Pistis M.; Muntoni A.L. | |
| Adolescent D9-Tetrahydrocannabinol Exposure Alters WIN55,212-2 Self-Administration in Adult Rats | 1-gen-2016 | Scherma, M.; Dessì, C.; Muntoni, A.L.; Lecca, S.; Satta, V.; Luchicchi, L.; Pistis, M.; Panlilio, L.V.; Fattore, L.; Goldberg, S.R.; Fratta, W.; Fadda, P. | |
| Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives | 1-gen-2016 | Scherma M.; Muntoni A.L.; Melis M.; Fattore L.; Fadda P.; Fratta W.; Pistis M. | |
| Maternal immune activation disrupts dopamine system in the offspring | 1-gen-2016 | Luchicchi A.; Lecca S.; Melis M.; De Felice M.; Cadeddu F.; Frau R.; Muntoni A.L.; Fadda P.; Devoto P.; Pistis M. | |
| PPAR modulation of mesolimbic dopamine transmission rescues depression-related behaviors | 1-gen-2016 | Scheggi S.; Melis M.; De Felice M.; Aroni S.; Muntoni A.L.; Pelliccia T.; Gambarana C.; De Montis M.G.; Pistis M. | |
| Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling | 1-gen-2015 | Dudok, B; Barna, L; Ledri, M; Szabo, Si; Szabadits, E; Pinter, B; Woodhams, Sg; Henstridge, Cm; Balla, Gy; Nyilas, R; Varga, C; Lee, Sh; Matolcsi, M; Cervenak, J; Kacskovics, I; Watanabe, M; Sagheddu, C; Melis, M; Pistis, M; Soltesz, I; Katona, I | |
| Endocannabinoid Signaling in Motivation, Reward, and Addiction: Influences on Mesocorticolimbic Dopamine Function | 1-gen-2015 | Sagheddu, C; Muntoni, Al; Pistis, M; Melis, M | |
| Enhanced serotonin and mesolimbic dopamine transmissions in a rat model of neuropathic pain | 1-gen-2015 | Sagheddu, C; Aroni, S; De Felice, M; Lecca, S; Luchicchi, A; Melis, M; Muntoni, Al; Romano, R; Palazzo, E; Guida, F; Maione, S; Pistis, M | |
| Enhanced endocannabinoid-mediated modulation of rostromedial tegmental nucleus drive onto dopamine neurons in sardinian alcohol-preferring rats | 1-gen-2014 | Melis, M; Sagheddu, C; Felice, Md; Casti, A; Madeddu, C; Spiga, S; Muntoni, Al; Mackie, K; Marsicano, G; Colombo, G; Castelli, Mp; Pistis, M |